97 related articles for article (PubMed ID: 7951272)
1. Multistage test procedure for testing Blackwelder's hypothesis of equivalence.
Lakshminarayanan MY; Patel HI; Stager WJ
J Biopharm Stat; 1994 Jul; 4(2):165-71. PubMed ID: 7951272
[TBL] [Abstract][Full Text] [Related]
2. Non-inferiority trials: the 'at least as good as' criterion.
Laster LL; Johnson MF
Stat Med; 2003 Jan; 22(2):187-200. PubMed ID: 12520556
[TBL] [Abstract][Full Text] [Related]
3. A treatment allocation procedure for sequential clinical trials.
Begg CB; Iglewicz B
Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
[TBL] [Abstract][Full Text] [Related]
4. Statistical analysis for two-stage seamless design with different study endpoints.
Chow SC; Lu Q; Tse SK
J Biopharm Stat; 2007; 17(6):1163-76. PubMed ID: 18027223
[TBL] [Abstract][Full Text] [Related]
5. Adaptive group sequential test for clinical trials with changing patient population.
Feng H; Shao J; Chow SC
J Biopharm Stat; 2007; 17(6):1227-38. PubMed ID: 18027228
[TBL] [Abstract][Full Text] [Related]
6. What does 'non-inferior to' really mean? A clinician thinking out loud.
Ricci S
Cerebrovasc Dis; 2010; 29(6):607-8. PubMed ID: 20413972
[TBL] [Abstract][Full Text] [Related]
7. A confirmatory strategy for therapeutic equivalence trials.
Kieser M
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):388-90. PubMed ID: 7582393
[TBL] [Abstract][Full Text] [Related]
8. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
Tsong Y; Shen M
J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
[TBL] [Abstract][Full Text] [Related]
9. Considerations for clinical trial design and data analyses of thorough QT studies using drug-drug interaction.
Zhu H; Wang Y; Gobburu JV; Garnett CE
J Clin Pharmacol; 2010 Oct; 50(10):1106-11. PubMed ID: 20457587
[No Abstract] [Full Text] [Related]
10. On tests of equivalence via non-unity relative risk for matched-pair design.
Tang NS; Tang ML; Chan IS
Stat Med; 2003 Apr; 22(8):1217-33. PubMed ID: 12687652
[TBL] [Abstract][Full Text] [Related]
11. Sequential design approaches for bioequivalence studies with crossover designs.
Potvin D; DiLiberti CE; Hauck WW; Parr AF; Schuirmann DJ; Smith RA
Pharm Stat; 2008; 7(4):245-62. PubMed ID: 17710740
[TBL] [Abstract][Full Text] [Related]
12. Testing for a treatment effect in the presence of nonresponders.
Boos DD; Brownie C
Biometrics; 1986 Mar; 42(1):191-7. PubMed ID: 3719056
[TBL] [Abstract][Full Text] [Related]
13. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
Bénichou J; Lepage E; Chastang C
Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
[TBL] [Abstract][Full Text] [Related]
14. An alternative to the use of two-sided tests in clinical trials.
Dunnett CW; Gent M
Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trials: issues for researchers.
Fetter MS; Feetham SL; D'Apolito K; Chaze BA; Fink A; Frink BB; Hougart MK; Rushton CH
Nurs Res; 1989; 38(2):117-20. PubMed ID: 2648334
[TBL] [Abstract][Full Text] [Related]
16. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
Lachin JM
Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
[TBL] [Abstract][Full Text] [Related]
17. A note on the power of Fisher's least significant difference procedure.
Meier U
Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
[TBL] [Abstract][Full Text] [Related]
18. Group sequential design and analysis of clinical equivalence assessment for generic nonsystematic drug products.
Tsong Y; Zhang JJ; Wang SJ
J Biopharm Stat; 2004 May; 14(2):359-73. PubMed ID: 15206533
[TBL] [Abstract][Full Text] [Related]
19. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
20. New tests for null hypothesis of non unity ratio of proportions.
Koti KM
J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
